Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Interest Expenses (2016 - 2025)

Cumberland Pharmaceuticals' Interest Expenses history spans 16 years, with the latest figure at $112942.0 for Q4 2025.

  • For Q4 2025, Interest Expenses fell 49.41% year-over-year to $112942.0; the TTM value through Dec 2025 reached $495990.0, up 3.51%, while the annual FY2025 figure was $495990.0, 18.09% down from the prior year.
  • Interest Expenses for Q4 2025 was $112942.0 at Cumberland Pharmaceuticals, up from $109699.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $223261.0 in Q4 2024 and bottomed at $20021.0 in Q3 2021.
  • The 5-year median for Interest Expenses is $119050.5 (2022), against an average of $119347.0.
  • The largest annual shift saw Interest Expenses tumbled 78.35% in 2021 before it surged 645.92% in 2022.
  • A 5-year view of Interest Expenses shows it stood at $27734.0 in 2021, then surged by 547.06% to $179456.0 in 2022, then crashed by 38.66% to $110081.0 in 2023, then surged by 102.82% to $223261.0 in 2024, then tumbled by 49.41% to $112942.0 in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Interest Expenses are $112942.0 (Q4 2025), $109699.0 (Q3 2025), and $109547.0 (Q2 2025).